Cargando…
Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT-CRP Induces Selective ROS-Dependent Apoptosis in T-Acute Lymphoblastic Leukemia Cell Lines
Immunotherapies strengthen the immune system to fight multiple diseases such as infections, immunodeficiencies, and autoimmune diseases, and recently, they are being used as an adjuvant in cancer treatment. IMMUNEPOTENT-CRP (I-CRP) is an immunotherapy made of bovine dialyzable leukocyte extract (bDL...
Autores principales: | Lorenzo-Anota, Helen Yarimet, Martínez-Torres, Ana Carolina, Scott-Algara, Daniel, Tamez-Guerra, Reyes S., Rodríguez-Padilla, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298273/ https://www.ncbi.nlm.nih.gov/pubmed/32587616 http://dx.doi.org/10.1155/2020/1598503 |
Ejemplares similares
-
The bovine dialyzable leukocyte extract, immunepotent CRP, synergically enhances cyclophosphamide-induced breast cancer cell death, through a caspase-independent mechanism
por: Rivera-Lazarín, Ana Luisa, et al.
Publicado: (2023) -
IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells
por: Martínez-Torres, Ana Carolina, et al.
Publicado: (2020) -
The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory
por: Reyes-Ruiz, Alejandra, et al.
Publicado: (2021) -
IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines
por: Lorenzo-Anota, Helen Y., et al.
Publicado: (2023) -
The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
por: Rodríguez-Salazar, Maria del Carmen, et al.
Publicado: (2017)